Loading...
A Dual 5α-Reductase Inhibitor Dutasteride Caused Reductions in Vascular Density and Area in Benign Prostatic Hyperplasia
Objectives. Dutasteride, a dual 5α-reductase inhibitor, is used to treat benign prostatic hyperplasia. Nevertheless, its histopathological effects on the morphometrics of blood vessels and glands are still controversial. The aim here was to assess the histopathological effects of dutasteride in case...
Saved in:
| Main Authors: | , , , , , , |
|---|---|
| Format: | Artigo |
| Language: | Inglês |
| Published: |
Hindawi Publishing Corporation
2013
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3562692/ https://ncbi.nlm.nih.gov/pubmed/23401800 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2013/863489 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|